Literature DB >> 1662805

Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains.

J M Gauthier1, J Dillner, M Yaniv.   

Abstract

In order to probe the structure of the transcription factor encoded by the E2 Open Reading Frame of papillomaviruses, we raised polyclonal antibodies against a series of synthetic peptides that cover the HPV16-E2 protein. In gel shift experiments with the native form of the protein, we detected supershifts (caused by the binding of antibodies to the E2-DNA complex) with antibodies synthesized against peptides covering a central region 50 residues long in the E2 protein. On the contrary, antibodies raised against peptides from the NH2- and COOH-termini did not give any supershifted band. Western blot experiments showed that several of these non reacting antibodies did however interact with the denatured protein. These results suggest that the central region that connects the NH2-terminal domain responsible for transcriptional activation and the COOH-domain involved in DNA-binding is exposed and maintained in a conformation resembling the peptide, indicating a high mobility region. In contrast, the DNA-binding and transactivation domains were not recognized by the antipeptide antibodies, in line with secondary structure predictions and sequence comparisons indicating that the E2 protein consists of structured and conserved NH2 and COOH-terminal regions separated by a non-conserved and unstructured region. This flexible 'hinge' region may facilitate contacts between E2 dimers at distance in mechanisms of transcriptional activation steps that involve homosynergy or DNA-looping.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662805      PMCID: PMC332517          DOI: 10.1093/nar/19.25.7073

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

Review 1.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

Review 2.  The atomic mobility component of protein antigenicity.

Authors:  J A Tainer; E D Getzoff; Y Paterson; A J Olson; R A Lerner
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

3.  General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.

Authors:  R A Houghten
Journal:  Proc Natl Acad Sci U S A       Date:  1985-08       Impact factor: 11.205

4.  Antibodies against synthetic peptides and the topology of LamB, an outer membrane protein from Escherichia coli K12.

Authors:  A Molla; A Charbit; A Le Guern; A Ryter; M Hofnung
Journal:  Biochemistry       Date:  1989-10-03       Impact factor: 3.162

Review 5.  An assessment of prediction methods for locating continuous epitopes in proteins.

Authors:  M H Van Regenmortel; G Daney de Marcillac
Journal:  Immunol Lett       Date:  1988-02       Impact factor: 3.685

Review 6.  Eukaryotic transcriptional regulatory proteins.

Authors:  P F Johnson; S L McKnight
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

7.  Anti-peptide antibodies and proteases as structural probes for the lactose/H+ transporter of Escherichia coli: a loop around amino acid residue 130 faces the cytoplasmic side of the membrane.

Authors:  R Seckler; T Möröy; J K Wright; P Overath
Journal:  Biochemistry       Date:  1986-05-06       Impact factor: 3.162

8.  Transcription in yeast activated by a putative amphipathic alpha helix linked to a DNA binding unit.

Authors:  E Giniger; M Ptashne
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

9.  The reactivity of anti-peptide antibodies is a function of the atomic mobility of sites in a protein.

Authors:  J A Tainer; E D Getzoff; H Alexander; R A Houghten; A J Olson; R A Lerner; W A Hendrickson
Journal:  Nature       Date:  1984 Nov 8-14       Impact factor: 49.962

10.  E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.

Authors:  A A McBride; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  13 in total

1.  Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.

Authors:  Xin Wang; Mei Qi; Xiuping Yu; Yan Yuan; Weiming Zhao
Journal:  J Gen Virol       Date:  2012-03-21       Impact factor: 3.891

2.  A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Authors:  Moon Kyoo Jang; D Eric Anderson; Koenraad van Doorslaer; Alison A McBride
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

3.  The human papillomavirus type 16 E2 transcription factor binds with low cooperativity to two flanking sites and represses the E6 promoter through displacement of Sp1 and TFIID.

Authors:  S H Tan; L E Leong; P A Walker; H U Bernard
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

4.  Equilibrium dissociation and unfolding of the dimeric human papillomavirus strain-16 E2 DNA-binding domain.

Authors:  Y K Mok; G de Prat Gay; P J Butler; M Bycroft
Journal:  Protein Sci       Date:  1996-02       Impact factor: 6.725

5.  Effect of bovine papillomavirus E2 protein-specific monoclonal antibodies on papillomavirus DNA replication.

Authors:  R Kurg; J Parik; E Juronen; T Sedman; A Abroi; I Liiv; U Langel; M Ustav
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

6.  The hinge of the human papillomavirus type 11 E2 protein contains major determinants for nuclear localization and nuclear matrix association.

Authors:  N Zou; B Y Lin; F Duan; K Y Lee; G Jin; R Guan; G Yao; E J Lefkowitz; T R Broker; L T Chow
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

7.  Two sequence motifs from HIF-1alpha bind to the DNA-binding site of p53.

Authors:  Lars O Hansson; Assaf Friedler; Stefan Freund; Stefan Rudiger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

8.  Interaction of the betapapillomavirus E2 tethering protein with mitotic chromosomes.

Authors:  Vandana Sekhar; Shawna C Reed; Alison A McBride
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

Review 9.  The papillomavirus E2 proteins.

Authors:  Alison A McBride
Journal:  Virology       Date:  2013-07-10       Impact factor: 3.616

10.  Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors.

Authors:  J M Gauthier; B Bourachot; V Doucas; M Yaniv; F Moreau-Gachelin
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.